Piramal Pharma Solutions Achieves Remarkable Net Promoter Score, Highlighting Commitment to Customer Satisfaction

Piramal Pharma Solutions Achieves Impressive Net Promoter Score

Piramal Pharma Solutions, a renowned global Contract Development and Manufacturing Organization (CDMO) under Piramal Pharma Ltd., has announced a significant achievement in customer satisfaction by securing a Net Promoter Score (NPS) of 55 for the fiscal year 2025. This score reflects a growing trend that positions Piramal Pharma at the forefront of the industry, demonstrating its commitment to maintaining excellent relationships with clients and stakeholders.

What is Net Promoter Score?

The NPS is a vital indicator of customer loyalty and satisfaction, measuring how likely customers are to recommend a company’s services or products. It is widely regarded in the business sector as a reliable metric for gauging customer satisfaction. Surveys are conducted annually, allowing businesses to understand their standing in the marketplace better and facilitate necessary adjustments in strategies and service delivery.

Piramal Pharma's NPS was verified by DNV, an established third-party assurance provider, ensuring that data integrity and transparency are upheld. This validation signifies the company's serious commitment to its clients and operational excellence.

Commitment to Stakeholder Centricity

Piramal Pharma Solutions has placed significant emphasis on stakeholder engagement, a principle that is at the core of the organization’s mission. This stakeholder-centric approach underlines its commitment to customers, patients, and consumers alike, shaping its operational strategies and business initiatives.

By focusing on feedback from customers and promoters through these surveys, the company gains valuable insights that inform future strategies, resulting in the continual refinement and enhancement of their services. These insights foster improved client engagement and operational efficiency, positioning Piramal Pharma as a trusted partner in the pharmaceutical manufacturing landscape.

Peter DeYoung, CEO of Piramal Global Pharma, remarked: “Our successful NPS score is not just a number; it’s an affirmation of our relentless pursuit of excellence in serving our customers. We don’t just intend to meet expectations; we aim to exceed them and create moments of customer delight.” This ethos is reflected in how the organization operates, ensuring their objectives align with the evolving needs of their stakeholders.

Beyond Customer Satisfaction

Piramal Pharma Solutions aims beyond mere customer satisfaction to create a culture of delight among its clients. The operational philosophy aims to strengthen long-term partnerships that enrich collaboration across various business sectors. It is this commitment that have ensured they far exceed the average negative NPS reported by several competing CDMOs, consolidating their reputation as leaders in the industry.

The insights derived from the surveys undertaken this year are set to shape the strategic initiatives of Piramal Pharma in the upcoming periods. The company intends to harness these insights to enhance client engagement further while maintaining a high standard of operational efficiency.

A Global Network of Excellence

Operating on a global scale with integrated facilities in North America, Europe, and Asia, Piramal Pharma Solutions provides end-to-end development and manufacturing services throughout the entire drug life cycle. Their offerings include drug discovery solutions, clinical trial supplies, and commercial supply of active pharmaceutical ingredients (APIs) among others.

Furthermore, the organization extends its reach with specialized services encompassing the development of highly potent APIs and biologics, including vaccines and gene therapies.

About Piramal Pharma Solutions illustrates that its commitment extends beyond numbers and metrics. The firm embodies values of transparency, accountability, and rigorous data integrity, ensuring stakeholders remain informed about their performance metrics.

In conclusion, Piramal Pharma Solutions continues to redefine service excellence in the pharmaceutical sector. With a keen focus on stakeholder needs, the company is set to enhance its offerings, creating additional value for customers, consumers, and patients worldwide.